These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 3020261)
1. Intermediate filament proteins as tissue specific markers in normal and malignant urological tissues. Feitz WF; Debruyne FM; Vooijs GP; Herman CJ; Ramaekers FC J Urol; 1986 Oct; 136(4):922-31. PubMed ID: 3020261 [TBL] [Abstract][Full Text] [Related]
2. Intermediate filament proteins in the study of tumor heterogeneity: an in-depth study of tumors of the urinary and respiratory tracts. Ramaekers FC; Moesker O; Huysmans A; Schaart G; Westerhof G; Wagenaar SS; Herman CJ; Vooijs GP Ann N Y Acad Sci; 1985; 455():614-34. PubMed ID: 3002221 [No Abstract] [Full Text] [Related]
7. [Study on heterotransplantation of malignant urogenital tumors in nude mice: results of transplantation and the characteristics of the explants]. Okada K; Yoshida O Hinyokika Kiyo; 1984 Dec; 30(12):1749-67. PubMed ID: 6085219 [TBL] [Abstract][Full Text] [Related]
11. [Tumor markers in the histopathology of urologic tumors]. Hofstädter F Urologe A; 1987 Jan; 26(1):2-6. PubMed ID: 3576859 [TBL] [Abstract][Full Text] [Related]
12. Referral pattern of urological malignancy in Indonesia. Sugandi S Br J Urol; 1989 Jan; 63(1):1-3. PubMed ID: 2537672 [TBL] [Abstract][Full Text] [Related]
13. [Immunohistochemical study of renal cell carcinoma. I. Immunohistochemical studies on the cell skeleton in human renal cell carcinoma with special emphasis on intermediate filaments]. Iizumi T; Yazaki T; Kanoh S; Koiso K; Koyama A; Tojo S Nihon Hinyokika Gakkai Zasshi; 1986 Jun; 77(6):878-85. PubMed ID: 3534403 [No Abstract] [Full Text] [Related]
14. Expression of intermediate filament proteins in subtypes of renal cell carcinomas and in renal oncocytomas. Distinction of two classes of renal cell tumors. Pitz S; Moll R; Störkel S; Thoenes W Lab Invest; 1987 Jun; 56(6):642-53. PubMed ID: 2439772 [TBL] [Abstract][Full Text] [Related]
15. The effect of cell extracts of urological tumours on adenovirus mutants. Csata S; Ongrádi J; Kulcsár G; Farkas J; Nász I Acta Chir Hung; 1987; 28(3):155-9. PubMed ID: 2444045 [TBL] [Abstract][Full Text] [Related]
16. Pathomics in urology. Schuettfort VM; Pradere B; Rink M; Comperat E; Shariat SF Curr Opin Urol; 2020 Nov; 30(6):823-831. PubMed ID: 32881725 [TBL] [Abstract][Full Text] [Related]
17. The cancer associated antigen test as an index to failure of complete removal of urological cancers. Wechsler M; Lo Gerfo P; Feminella J; Lattimer JK Trans Am Assoc Genitourin Surg; 1972; 64():85-7. PubMed ID: 4347503 [No Abstract] [Full Text] [Related]
18. [Intermediate filament proteins as markers in tumor diagnosis]. Altmannsberger M Veroff Pathol; 1988; 127():1-105. PubMed ID: 3341148 [TBL] [Abstract][Full Text] [Related]
19. Pattern of urological malignancy in Zambia. A hospital-based histopathological study. Elem B; Patil PS Br J Urol; 1991 Jan; 67(1):37-9. PubMed ID: 1847087 [TBL] [Abstract][Full Text] [Related]
20. Human urologic cancer cell lines. Williams RD Invest Urol; 1980 Mar; 17(5):359-63. PubMed ID: 6244232 [No Abstract] [Full Text] [Related] [Next] [New Search]